Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Receivables (2022 - 2025)

HeartSciences filings provide 4 years of Receivables readings, the most recent being $4350.0 for Q2 2025.

  • On a quarterly basis, Receivables changed N/A to $4350.0 in Q2 2025 year-over-year; TTM through Apr 2025 was $4350.0, a N/A change, with the full-year FY2025 number at $4350.0, changed N/A from a year prior.
  • Receivables hit $4350.0 in Q2 2025 for HeartSciences, down from $14700.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $14700.0 in Q1 2024 to a low of $2321.0 in Q2 2022.
  • Median Receivables over the past 4 years was $4125.0 (2023), compared with a mean of $6317.8.